Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells
about
Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumorsMatricellular proteins: a sticky affair with cancersEndogenous thrombospondin-1 regulates leukocyte recruitment and activation and accelerates death from systemic candidiasisTherapeutic opportunities for targeting the ubiquitous cell surface receptor CD47Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signalingMechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancerA novel cancer therapeutic using thrombospondin 1 in dendritic cellsSignaling and stress: The redox landscape in NOS2 biologyCD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis.Aberrant methylation of thrombospondin-1 and its association with reduced expression in gastric cardia adenocarcinomaTumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growthThrombospondin-1 contributes to mortality in murine sepsis through effects on innate immunity.Thrombospondin1 deficiency reduces obesity-associated inflammation and improves insulin sensitivity in a diet-induced obese mouse model.PDT-induced HSP70 externalization up-regulates NO production via TLR2 signal pathway in macrophages.sFRP-1 binds via its netrin-related motif to the N-module of thrombospondin-1 and blocks thrombospondin-1 stimulation of MDA-MB-231 breast carcinoma cell adhesion and migration.Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.The thrombospondins.Thrombospondin-1: an extracellular message delivered by macrophages that promotes aortic aneurysmsEffect of Negative Pressure Therapy on the Inflammatory Response of the Intestinal Microenvironment in a Porcine Septic Model.Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.Secreted Thrombospondin-1 Regulates Macrophage Interleukin-1β Production and Activation through CD47.Thrombospondin-1 and pigment epithelium-derived factor enhance responsiveness of KM12 colon tumor to metronomic cyclophosphamide but have disparate effects on tumor metastasis.The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesisCD47 signaling pathways controlling cellular differentiation and responses to stress.Tumor-stromal interactions in pancreatic cancerNoncanonical roles of the immune system in eliciting oncogene addictionThrombospondin-1 is a putative target gene of Runx2 and Runx3.Thrombospondin-1 regulates adiposity and metabolic dysfunction in diet-induced obesity enhancing adipose inflammation and stimulating adipocyte proliferationProsaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapiesIntermittent metronomic drug schedule is essential for activating antitumor innate immunity and tumor xenograft regression.Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesotheliomaPerindopril Induces TSP-1 Expression in Hypertensive Patients with Endothelial Dysfunction in Chronic Treatment.Innate immune cells in breast cancer--from villains to heroes?Immunology in the clinic review series; focus on cancer: multiple roles for the immune system in oncogene addiction.Mechanisms of action of tasquinimod on the tumour microenvironment.Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease."UPRegulation" of CD47 by the endoplasmic reticulum stress pathway controls anti-tumor immune responses.Regulation of cellular redox signaling by matricellular proteins in vascular biology, immunology, and cancerDevelopment of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment.
P2860
Q21245714-765D5F09-322B-41D0-A4B5-06B4958F32E8Q21296660-CC4CA0B4-A0FB-49C6-B6C0-601805826544Q24303620-BDB50535-2123-4115-8F5A-0AE337B43584Q24627155-8F221339-A1A8-4A7F-83D8-2E88DC50C125Q24657627-856BC4E3-801A-4FA4-835D-5B7D6C7EB775Q27024795-2EF280C0-9785-473C-AA17-D49B751D0C5EQ28395685-E286B0BF-AF57-4328-B6DA-CFFCD425FAAEQ28833738-3F456A4F-2927-47AC-A8EF-C58CB3429258Q33618348-3FF39B60-9CFD-4EE2-9B29-0998D062909BQ33726742-BCC33387-4F18-49C2-A1D7-607C273CD37FQ33770873-028B2FEC-DDE0-4F22-BF1B-0878E4BE0AB0Q33900363-8459A8B5-F5D6-45D5-A534-884A80EF7F28Q34062545-EC0B2995-E333-4135-8CC0-FAECE4E411CCQ34514646-A6F02926-91C3-4FF9-A403-42E2E52EFF5CQ34904445-92E93C72-9ECC-42B2-ABD2-D29AAA41AA59Q34973731-47ABCA6B-BC3D-4381-992B-722FDA47A608Q35230013-E4465F31-82D5-4CC3-A809-91BF25EC3BC8Q35825173-19257770-0CC4-4A6D-8F20-7318F14B380BQ35947275-8BBE994D-EA66-48CF-B881-C1C46BAFA2C7Q36079101-07C3D4E3-7B3A-41EA-85BF-26E00D2E38A5Q36507239-A2FDE88A-8997-4BBA-B680-63C635DA1612Q36586178-75DEFD61-C6D0-4247-A9B9-A5BD236A8C02Q36632900-DBC9C122-7CCA-4BD1-B621-B0B6A39501B9Q36771076-1AFECA4F-1836-4086-8CAB-78CEA06185FDQ36784603-51B84077-AA5F-499D-A174-10EB0075EAB5Q36931816-966B5AA5-82B1-4616-B20D-C42AE0FADC75Q37091945-231E7FD8-18C3-4C9C-AA96-CA85E972FE93Q37093613-4A9AC958-39F1-4976-826B-4F46FC712EC4Q37274430-A5DA268F-D593-4633-AE51-D29EFAF2B7B2Q37385797-811E6F37-6430-49D8-87C0-85B0CEDA45EAQ37584300-E5EE52BC-5D51-4B08-A216-D7FBB6D18A9AQ37623620-E9BB245D-5E30-402C-A574-4561666EEC90Q37690844-F99195B8-7590-47B5-9785-B655E5FF100DQ37905673-C0C15D09-4C9B-45B5-84C8-FE3BD680A93DQ37974936-9E92D503-EBFA-4A84-A295-05680A08BDF2Q38155757-7CB00118-36C4-449D-81E5-DE724B014D6FQ38177946-B71703C0-2DD9-4582-BB2B-0DBDE81A76CDQ38621233-307D613D-E0F0-4B5C-909F-F113A0B10A8FQ38656989-2E84BFBC-DFB0-407E-B5B0-85BA0922D7B7Q38787442-BD86F384-5009-4072-AE84-34EC5823AF86
P2860
Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Thrombospondin 1 promotes tumo ...... y of differentiated U937 cells
@ast
Thrombospondin 1 promotes tumo ...... y of differentiated U937 cells
@en
Thrombospondin 1 promotes tumo ...... y of differentiated U937 cells
@en-gb
Thrombospondin 1 promotes tumo ...... y of differentiated U937 cells
@nl
type
label
Thrombospondin 1 promotes tumo ...... y of differentiated U937 cells
@ast
Thrombospondin 1 promotes tumo ...... y of differentiated U937 cells
@en
Thrombospondin 1 promotes tumo ...... y of differentiated U937 cells
@en-gb
Thrombospondin 1 promotes tumo ...... y of differentiated U937 cells
@nl
prefLabel
Thrombospondin 1 promotes tumo ...... y of differentiated U937 cells
@ast
Thrombospondin 1 promotes tumo ...... y of differentiated U937 cells
@en
Thrombospondin 1 promotes tumo ...... y of differentiated U937 cells
@en-gb
Thrombospondin 1 promotes tumo ...... y of differentiated U937 cells
@nl
P2093
P2860
P921
P3181
P1433
P1476
Thrombospondin 1 promotes tumo ...... y of differentiated U937 cells
@en
P2093
David A Wink
Gema Martin-Manso
Lisa A Ridnour
Maria Tsokos
Susana Galli
P2860
P304
P3181
P356
10.1158/0008-5472.CAN-08-0643
P407
P577
2008-09-01T00:00:00Z